» Articles » PMID: 20660562

The Receptor Subunits Generating NMDA Receptor Mediated Currents in Oligodendrocytes

Overview
Journal J Physiol
Specialty Physiology
Date 2010 Jul 28
PMID 20660562
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

NMDA receptors have been shown to contribute to glutamate-evoked currents in oligodendrocytes. Activation of these receptors damages myelin in ischaemia, in part because they are more weakly blocked by Mg(2+) than are most neuronal NMDA receptors. This weak Mg(2+) block was suggested to reflect an unusual subunit composition including the NR2C and NR3A subunits. Here we expressed NR1/NR2C and triplet NR1/NR2C/NR3A recombinant receptors in HEK cells and compared their currents with those of NMDA-evoked currents in rat cerebellar oligodendrocytes. NR1/NR2C/3A receptors were less blocked by 2 mM Mg(2+) than were NR1/NR2C receptors (the remaining current was 30% and 18%, respectively, of that seen without added Mg(2+)) and showed less channel noise, suggesting a smaller single channel conductance. NMDA-evoked currents in oligodendrocytes showed a Mg(2+) block (to 32%) similar to that observed for NR1/NR2C/NR3A and significantly different from that for NR1/NR2C receptors. Co-immunoprecipitation revealed interactions between NR1, NR2C and NR3A subunits in a purified myelin preparation from rat brain. These data are consistent with NMDA-evoked currents in oligodendrocytes reflecting the activation of receptors containing NR1, NR2C and NR3A subunits.

Citing Articles

Changes in kynurenine metabolites in the gray and white matter of the dorsolateral prefrontal cortex of individuals affected by schizophrenia.

Antenucci N, DErrico G, Fazio F, Nicoletti F, Bruno V, Battaglia G Schizophrenia (Heidelb). 2024; 10(1):27.

PMID: 38413629 PMC: 10899223. DOI: 10.1038/s41537-024-00447-3.


Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry.

Hanson J, Yuan H, Perszyk R, Banke T, Xing H, Tsai M Neuropsychopharmacology. 2023; 49(1):51-66.

PMID: 37369776 PMC: 10700609. DOI: 10.1038/s41386-023-01614-3.


Pharmacological Potential of 3-Benzazepines in NMDAR-Linked Pathophysiological Processes.

Ritter N, Disse P, Wunsch B, Seebohm G, Strutz-Seebohm N Biomedicines. 2023; 11(5).

PMID: 37239037 PMC: 10216354. DOI: 10.3390/biomedicines11051367.


The Emerging Role of N-Methyl-D-Aspartate (NMDA) Receptors in the Cardiovascular System: Physiological Implications, Pathological Consequences, and Therapeutic Perspectives.

Soda T, Brunetti V, Berra-Romani R, Moccia F Int J Mol Sci. 2023; 24(4).

PMID: 36835323 PMC: 9965111. DOI: 10.3390/ijms24043914.


Alteration in NMDAR subunits in different brain regions of chronic unpredictable mild stress (CUMS) rat model.

Chen J, Luo Y, Liang X, Kong X, Xiao Q, Tang J Transl Neurosci. 2022; 13(1):379-389.

PMID: 36348956 PMC: 9601380. DOI: 10.1515/tnsci-2022-0255.


References
1.
Fu Y, Sun W, Shi Y, Shi R, Cheng J . Glutamate excitotoxicity inflicts paranodal myelin splitting and retraction. PLoS One. 2009; 4(8):e6705. PMC: 2725320. DOI: 10.1371/journal.pone.0006705. View

2.
Lipton S, Rosenberg P . Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994; 330(9):613-22. DOI: 10.1056/NEJM199403033300907. View

3.
Bakiri Y, Hamilton N, Karadottir R, Attwell D . Testing NMDA receptor block as a therapeutic strategy for reducing ischaemic damage to CNS white matter. Glia. 2007; 56(2):233-40. PMC: 2863073. DOI: 10.1002/glia.20608. View

4.
Tessier-Lavigne M, Attwell D, Mobbs P, Wilson M . Membrane currents in retinal bipolar cells of the axolotl. J Gen Physiol. 1988; 91(1):49-72. PMC: 2216120. DOI: 10.1085/jgp.91.1.49. View

5.
Dingledine R, Borges K, Bowie D, Traynelis S . The glutamate receptor ion channels. Pharmacol Rev. 1999; 51(1):7-61. View